Quarterly Newsletter: Fall 2024 ?? We're excited to share the latest advancements, achievements, and innovations from our team. In this issue, you'll discover how PathAI is continuing to revolutionize the field of #pathology with cutting-edge #AI technologies, groundbreaking research, and inspiring collaborations. Learn about the strides we've made in improving #digitalpathology, enhancing #drugdevelopment, and shaping the future of #healthcare.
PathAI
软件开发
Boston,Massachusetts 57,315 位关注者
Improving patient outcomes with AI-powered pathology.
关于我们
PathAI's mission is to improve patient outcomes with AI-powered pathology. Our platform promises substantial improvements to the accuracy of diagnosis and the efficacy of treatment of diseases like cancer, leveraging modern approaches in machine learning. We are a company of diverse employees with a wide range of backgrounds and experiences. Our world class team is passionate about solving challenging problems and making a huge impact. Our office is located in the heart of Fenway. PathAI was recently voted one of BBJ's Best Places to Work!
- 网站
-
https://www.pathai.com
PathAI的外部链接
- 所属行业
- 软件开发
- 规模
- 501-1,000 人
- 总部
- Boston,Massachusetts
- 类型
- 私人持股
- 创立
- 2016
- 领域
- artificial intelligence、pathology、digital pathology、oncology、immuno-oncology、auto immune disease、neurodegenerative disease、companion diagnostics、precision medicine、R&D、computational pathology、deep learning、software engineering、AI、Machine Learning、IBD、cancer research、oncology research、Drug Development、CRO 、Clinical development、healthtech和Artificial Intelligence
地点
PathAI员工
动态
-
?? PathAI is proud to announce Eric Walk MD, FCAP's recognition on the #PharmaVoice100 list??? “Eric’s unwavering dedication to advancing #pathology and #healthcare technology, coupled with his ability to forge strategic #partnerships with physicians, patients and industry partners is distinctive. He is a well deserving recipient of the PharmaVoice 100 recognition. He is an inspiration to all of us at PathAI,” said Dr. Andrew Beck, CEO at PathAI.? Learn more: https://lnkd.in/eCHEjuAm #AI #AIPathology #digitalpathology #pharma #biopharma #PharmaVoice #biotech #biotechnology #precisionmedicine #healthtech
-
We're live at #UEGWeek in Vienna, Austria! Visit us in the Innovation Hub to discuss the utilization of #AIPathology for comprehensive and quantitative insights for #IBD & #UlcerativeColitis research. See live demos of IBD Explore? and AIM HI-UC? (Ulcerative Colitis), and learn more about vertically integrated #digitalpathology solutions & services across the #drugdevelopment lifecycle View our virtual booth: https://lnkd.in/eTVsBzUN Presentation Highlight: Join Christina Jayson, Ph.D. at #UEGWeek for her presentation on?“#AI-powered histology in Inflammatory Bowel Disease: deeper insights for #biomarker discovery and drug development” and to see a case study from our UEG ePoster with leaders in the IBD space. ??? Tomorrow: Monday, October 14, 2024? ? Time: 12:30-13:00 & 15:30-16:00 ?? Where: The Innovation Hub ?? Add to your schedule: https://lnkd.in/gxEjR9n IBD Explore? and AIM HI-UC? is for research use only. Not for use in diagnostic procedures.
-
Our Co-Founder and CEO, Andrew Beck will be speaking at the MIT AI Conference! This event brings together thought leaders and innovators to explore the transformative impact of artificial intelligence across various industries. Join Andy and numerous other leaders for insightful discussions, networking opportunities, and real-world case studies highlighting how AI shapes the future of robotics, safety, Finance, #Healthcare, and many others. ??? Date: October 26, 2024 ?? Location: 225 Liberty St, New York, NY 10080? ??? Register here: https://lu.ma/mitai2024 ? Special Offer: Use code PATHAI10 for a discount on your ticket! See you there and engage in meaningful conversations about the future of AI. Let’s connect and share ideas on leveraging technology for positive change!? #MITAI2024 #ArtificialIntelligence #Innovation #AIConference #AIPathology #Pathology
-
PathAI is excited to announce a new #partnership with Clario, combining AI-powered #digitalpathology and #endoscopy solutions geared towards enhancing #drugdevelopment for inflammatory bowel disease and other GI disorders. “Our collaboration will offer an integrated approach in #histology and endoscopy for assessing therapeutic efficacy, accelerating biomarker discovery and therapy development in IBD,” said Matt Grow, Chief Business Officer & President of Biopharma at PathAI. Read more in our recent #PressRelease: https://lnkd.in/eW4ZWXJr #AIPathology #IBD #pathology #biotech #biotechnology #clinicaltrials #biopharma #PrecisionMedicine #biomarkers #drugdiscovery #drugdevelopment
-
Attending #CAP2024? Stop by PathAI’s booth #406 to discover how AISight IMS empowers labs with advanced digital and AI-powered tools. Learn how AISight streamlines case management and optimizes pathology workflows, ensuring your lab stays efficient and ahead of the curve. ?? Schedule your demo today: https://lnkd.in/g97kHdMr In addition to our booth activities, we are also hosting an exclusive dinner on the evening of October 19, 2024. This invite-only event will bring together a distinguished group of leading pathologists and industry experts for an evening of great food and insightful conversation. ?? If you're interested to learn more or would like to attend this dinner, fill out the form https://lnkd.in/gGSmEKhs #CAP #pathai #digitalpathology #aipathology #aiheathcare AISight is for research use only. Not for use in diagnostic procedures.
-
?? Last week, the global PathAI team came together at our Boston headquarters for an inspiring week of #collaboration and #growth. ?? We shared groundbreaking innovations from across departments, explored the future of #AI in #healthcare, and took time to give back to the local community during our annual #CommunityDay. Thank you to City Year Greater Boston for your passion for community and for organizing this special event! At PathAI, our mission is to transform patient care by harnessing the power of #AI in #pathology, advancing life-saving treatments, and improving diagnostic precision. Learn more about our team, culture, and mission: https://lnkd.in/eBg63JW ? Our Values ? Patients First We embody a patient-first mindset with everything we do and are committed to meeting the needs of our customers to improve patient outcomes. Accountability We set out to accomplish the tasks we commit to and take responsibility for our work, and our actions. Team We are One PathAI, all working towards the same goal. We trust our teammates and count on each other to get the job done. Humility We know all that we do matters, big and small. We value openness, we are accepting of others, and are curious to learn from each other. All In We are all passionate about our mission and our passion pushes us to be better every day.
-
We’re heading to #UEGWeek in Vienna, Austria! Visit us in the Innovation Hub and request a meeting to discuss the utilization of #AIPathology for comprehensive and quantitative insights for #IBD & #UlcerativeColitis research. See live #demos of IBD Explore? & AIM HI-UC? and learn more about vertically integrated #digitalpathology solutions & services across the #drugdevelopment lifecycle. Schedule a meeting with us: https://lnkd.in/eTVsBzUN Presentation Highlight: Join Christina Jayson at #UEGWeek for her presentation on “AI-powered histology in Inflammatory Bowel Disease: deeper insights for biomarker discovery and drug development” and to see a case study from our UEG ePoster with leaders in the IBD space. ??? When: Monday, October 14, 2024? ? Time: 12:30-13:00 & 15:30-16:00 ?? Where: The Innovation Hub ?? Add to your schedule: https://lnkd.in/gxEjR9n IBD Explore? and AIM HI-UC? is for research use only. Not for use in diagnostic procedures. #biotech #UEG2024 #UEG #pathology #AI #MachineLearning #biotechnology #healthtech #innovation
-
We’re heading to #CAP2024 in Las Vegas, October 19-22! Let’s connect! Schedule a meeting with our team to explore how AISight IMS transforms pathology workflows and enhances case management for improved efficiency. Visit us at booth #406 to see how AISight provides seamless access to embedded AI algorithms, helping pathologists make efficient and reproducible assessments. ?? Register for a demo: https://lnkd.in/g97kHdMr #CAP #pathai #digitalpathology #aipathology #aiheathcare #anatomicpathology #imagementmanagementsystem AISight is for research use only. Not for use in diagnostic procedures.
-
?? PathAI is excited to announce a new #partnership with the Crohn's & Colitis Foundation. The collaboration will empower academic and #biopharmaceutical researchers to unlock insights into Inflammatory Bowel Disease (IBD) through the unique combination of the well-characterized multi-modal clinical & molecular data from the Crohn’s & Colitis Foundation’s #IBD Plexus dataset, and quantitative #histopathology data derived from PathAI’s suite of proprietary algorithms in IBD. The partnership fuels our mission to transform #drugdevelopment and patient outcomes in IBD with AI-powered #pathology. Link to press release: https://lnkd.in/eVH8RxVn #digitalpathology #AI #inflammatoryboweldisease #IBD #drugdiscovery #biomarkers #RWD #RealWorldData #AIPathology #biotech #genomics #BigData #healthtech